Biocon arm, Mylan launch diabetes drug Semglee in US Medical Dialogues Bureau1 Sept 2020 10:45 AM IST"The commercialization of our insulin glargine in the US represents another milestone achievement for Biocon in making insulin-based therapy...
Biocon Chairman Kiran Mazumdar Shaw tests positive for COVID-19 Farhat Nasim18 Aug 2020 5:11 PM ISTBengaluru: In an unfortunate incident, the Chairman of Bengaluru-based drugmaker Biocon- Kiran Mazumdar Shaw has been tested positive for fatal...
Tata Capital Growth Fund to invest Rs 225 crore in Biocon Biologics Ruchika Sharma1 Aug 2020 11:42 AM ISTPost the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.
Biocon to furnish more data for consideration of Itolizumab in treating COVID patients Farhat Nasim29 July 2020 4:24 PM ISTBengaluru: After facing rejection from the Health Ministry, Bengaluru-based drugmaker Biocon is now preparing to present 'more data' for consideration...
Setback to Biocon: Health Ministry Says NO To Psoriasis Drug Itolizumab In Clinical Management Protocols For COVID-19 Ruchika Sharma27 July 2020 3:59 PM ISTNew Delhi: In a major setback to drug major, Biocon, the National Task Force on COVID-19 has decided against including Itolizumab drug in clinical...
Biocon net profit falls 26 percent to Rs 167.8 crore in Q1 Medical Dialogues Bureau26 July 2020 9:45 AM ISTBengaluru: Biotechnology major Biocon has reported a 26.30 percent decline in its consolidated net profit at Rs 167.8 crore for the quarter ended June...
Biocon Biologics, Voluntis collaborate for digital therapeutics for diabetics patients Ruchika Sharma22 July 2020 1:22 PM ISTNew Delhi: Biocon Biologics on Tuesday announced a global collaboration agreement with Voluntis to develop and distribute digital therapeutics...
CONTROVERSY: DCGI exempts Biocon from Phase 3 trial of COVID drug Itolizumab, ICMR sees red Farhat Nasim17 July 2020 4:21 PM ISTBengaluru: In a major controversy, the exemption of biotechnology major Biocon from conducting Phase 3 trials of its psoriasis drug...
Biocon Itolizumab gets DCGI nod to treat COVID-19 patients Ruchika Sharma13 July 2020 1:28 PM ISTItolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru.
Biocon to invest over Rs 1493 crore capex for current fiscal Ruchika Sharma4 July 2020 1:40 PM ISTThe capex will be funded through a combination of contribution from internal accruals, debt raise as well as an additional private equity investment...
Biocon Chief condemns ICMR for not permitting Asymptomatic Testing Ruchika Sharma27 Jun 2020 11:55 AM ISTBengaluru: Biotechnology industry veteran Kiran Mazumdar-Shaw on Friday criticised the Indian Council of Medical Research for "not permitting"...
Biocon, DKSH ink pact to commercialize 7 generic formulations in Singapore, Thailand Ruchika Sharma23 Jun 2020 1:08 PM ISTUnder the terms of the agreement, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various...
